Clin2
NCT02192866Possibly a fitRecruiting

Blood samples to study peanut and tree nut allergies

Peanut AllergiesTree Nut AllergiesOther Food Allergies

Part of Immune system & allergy clinical trials.

This study collects blood (or uses already-collected blood) to learn why peanut, tree nut, and related food allergies happen and how they behave during challenges. It may help researchers better understand allergies and improve future care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
270 people
Ages
1 year to 75 years
Study type
Observational

Who can take part

  • You are between 1 and 75 years old (depending on the group)
  • You have peanut allergy and a history of a whole-body (systemic) reaction, or you’re a peanut allergy normal-control group
  • Or you have tree nut or other food allergies with a history of a whole-body reaction
  • Or you are currently undergoing a medically needed peanut food challenge
  • Or you participated in a peanut oral immunotherapy (OIT) trial and had at least one oral challenge
  • You do not have a major medical or psychiatric condition known to affect the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07775430Not yet recruiting
Peanut allergy blood test study

This study is testing a new blood test for peanut allergy. If you join, you will give a few extra blood samples during a regular blood draw. The test may help doctors better diagnose peanut allergies.

NCT07764159Not yet recruiting
Mixed nut oral immunotherapy for children with multiple nut allergies

This study tests a treatment that slowly builds tolerance to multiple nut allergens (peanut and tree nuts) in children with allergies. It aims to reduce the risk of severe reactions from accidental exposure.

Poznan, Greater Poland Voivodeship
NCT07701954Recruiting· Phase 1
Testing a new drug for people with allergies and high IgE

This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.

Mississauga, Ontario
NCT07117669Recruiting· Phase 1/Phase 2
Testing a new peanut allergy treatment (ENP-501)

This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.

Aurora, Colorado
NCT05521711Recruiting
Testing an at-home route for tree nut allergy immunotherapy

This study tests how a specific form of treatment is given to people with a tree nut allergy. The goal is to find a safer, more effective way to help your body tolerate tree nuts.

Hamilton, Ontario
NCT07279467Recruiting
Peanut allergy food challenge biomarker study

This study aims to identify markers in the blood that could help predict how severe a peanut allergy reaction might be. If you qualify, your child will undergo a supervised peanut challenge to see how their body responds.

Little Rock, Arkansas

Hear when a new Peanut Allergies trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.